| Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. | |
| | |
MedLine Citation:
|
PMID: 11571238 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Because plaque inflammation may modulate coronary vasomotion, the association between systemic levels of C-reactive protein (CRP) and coronary vasoreactivity was assessed in patients with stable or unstable angina. METHODS AND RESULTS: In 31 patients with stable angina and 23 patients with unstable angina undergoing coronary angiography, minimal luminal diameter (MLD) of the culprit lesion was measured by quantitative coronary angiography at baseline, during the cold pressor test (CPT), and after intracoronary administration of nitroglycerin (NTG) and expressed as percent change from baseline. MLD of patients with unstable angina exhibited a greater reduction during CPT and a greater increase after NTG than did patients with stable angina (-17+/-14% versus -5+/-12%, P=0.0013, and 34+/-25% versus 8+/-20%, P<0.001, respectively). According to preprocedural serum levels of CRP, 36 patients had normal (</=0.5 mg/dL) and 18 patients had elevated CRP levels. MLD of patients with elevated CRP levels exhibited a greater reduction during CPT and a greater increase after NTG than of patients with normal CRP levels (-15+/-12% versus -7+/-14%, P=0.037, and 31+/-23% versus 13+/-25%, P=0.011, respectively). Both unstable angina and elevated CRP levels resulted in independent predictors of enhanced vasoreactivity at the multivariate analysis. CONCLUSIONS: This study confirms enhanced vasoreactivity of the culprit lesion in patients with unstable angina compared with those with stable angina. More importantly, it demonstrates that inflammatory mechanisms play a key role in modulating the reactivity of coronary atherosclerotic plaques and may partially account for the enhanced vasoreactivity of the unstable plaques. |
| | |
Authors:
|
F Tomai; F Crea; A Gaspardone; F Versaci; A S Ghini; L Chiariello; P A Gioffrè |
Related Documents
:
|
20082878 - Human parvovirus b19 infection in patients with coronary atherosclerosis. 15983678 - Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activati... 7960858 - Distressful events in the icu as perceived by patients recovering from coronary artery ... 8187568 - Percutaneous transluminal excimer laser coronary angioplasty. clinical report of six ca... 2555628 - Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients ... 12136898 - Mortality and morbidity in peripheral neuropathy associated churg-strauss syndrome and ... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Circulation Volume: 104 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2001 Sep |
Date Detail:
|
Created Date: 2001-09-25 Completed Date: 2001-10-11 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 1471-6 Citation Subset: AIM; IM |
Affiliation:
|
Cattedra di Cardiochirurgia, Università di Roma Tor Vergata, Rome, Italy. f.tomai@tiscalinet.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Angina, Unstable / metabolism, physiopathology* Blood Pressure C-Reactive Protein / metabolism* Cardiovascular Abnormalities / diagnosis*, physiopathology Coronary Angiography Female Heart Rate Humans Inflammation / etiology Male Middle Aged Multivariate Analysis Prognosis Vasomotor System / physiopathology* |
| Chemical | |
Reg. No./Substance:
|
9007-41-4/C-Reactive Protein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
Next Document: Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.